Matches in SemOpenAlex for { <https://semopenalex.org/work/W2582168067> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2582168067 endingPage "40" @default.
- W2582168067 startingPage "34" @default.
- W2582168067 abstract "As patients attending hospitals of different grades in China may receive different medical care, we investigated the clinical efficacy and safety of routine insulin therapy in patients with type 2 diabetes who were treated at grade 2 and grade 3 (highest grade) hospitals in China.2683 patients with type 2 diabetes were enrolled in a multicenter, nonrandomized, open-label, noninterventional, 12-week clinical trial performed at 62 Chinese hospitals. Patients were divided into two groups according to the hospitals' grading. Data were analyzed for efficacy (changes and normalization of glycated hemoglobin [HbA1c] and changes in fasting plasma glucose and 2-h postprandial blood glucose [PBG] levels from baseline to the final visit) and for safety (hypoglycemia).After 12 weeks of routine human insulin (SciLin) therapy, decreases in mean HbA1c and PBG levels were significantly greater in patients treated at second-grade hospitals (all P < 0.001 vs. third-grade hospitals), and the HbA1c success rate (<7%) was significantly higher (46.94% vs. 38.85%; P = 0.0002). However, patients treated at second-grade hospitals had more weight gain (0.29 kg vs. 0.04 kg; P < 0.0001) and a higher incidence of total hypoglycemic events (21.82% vs. 16.79%; P = 0.0002).Routine insulin treatment of patients with type 2 diabetes in China demonstrates acceptable safety and effectiveness, improving blood glucose control with a low incidence of severe hypoglycemia. Patients treated at second-grade hospitals had a greater HbA1c success rate than those treated at third-grade hospitals, but with more weight gain and more hypoglycemic events." @default.
- W2582168067 created "2017-02-03" @default.
- W2582168067 creator A5002551939 @default.
- W2582168067 creator A5008318052 @default.
- W2582168067 creator A5012119333 @default.
- W2582168067 creator A5031646804 @default.
- W2582168067 creator A5031873259 @default.
- W2582168067 creator A5072686236 @default.
- W2582168067 date "2017-01-01" @default.
- W2582168067 modified "2023-10-12" @default.
- W2582168067 title "Efficacy and Safety of Insulin Therapy in Patients with Type 2 Diabetes Treated at Different Grades of Hospitals in China: Subgroup Analysis of the Real-World SEAS Study" @default.
- W2582168067 cites W2009756430 @default.
- W2582168067 cites W2053369310 @default.
- W2582168067 cites W2111389530 @default.
- W2582168067 cites W2122604582 @default.
- W2582168067 cites W2125015574 @default.
- W2582168067 cites W2130266732 @default.
- W2582168067 cites W2140672693 @default.
- W2582168067 cites W2146041442 @default.
- W2582168067 cites W4205288846 @default.
- W2582168067 doi "https://doi.org/10.1089/dia.2016.0305" @default.
- W2582168067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28001434" @default.
- W2582168067 hasPublicationYear "2017" @default.
- W2582168067 type Work @default.
- W2582168067 sameAs 2582168067 @default.
- W2582168067 citedByCount "1" @default.
- W2582168067 countsByYear W25821680672023 @default.
- W2582168067 crossrefType "journal-article" @default.
- W2582168067 hasAuthorship W2582168067A5002551939 @default.
- W2582168067 hasAuthorship W2582168067A5008318052 @default.
- W2582168067 hasAuthorship W2582168067A5012119333 @default.
- W2582168067 hasAuthorship W2582168067A5031646804 @default.
- W2582168067 hasAuthorship W2582168067A5031873259 @default.
- W2582168067 hasAuthorship W2582168067A5072686236 @default.
- W2582168067 hasConcept C120665830 @default.
- W2582168067 hasConcept C121332964 @default.
- W2582168067 hasConcept C126322002 @default.
- W2582168067 hasConcept C134018914 @default.
- W2582168067 hasConcept C2777180221 @default.
- W2582168067 hasConcept C2777538456 @default.
- W2582168067 hasConcept C2778199505 @default.
- W2582168067 hasConcept C2779306644 @default.
- W2582168067 hasConcept C2780473172 @default.
- W2582168067 hasConcept C2780668416 @default.
- W2582168067 hasConcept C555293320 @default.
- W2582168067 hasConcept C61511704 @default.
- W2582168067 hasConcept C71924100 @default.
- W2582168067 hasConceptScore W2582168067C120665830 @default.
- W2582168067 hasConceptScore W2582168067C121332964 @default.
- W2582168067 hasConceptScore W2582168067C126322002 @default.
- W2582168067 hasConceptScore W2582168067C134018914 @default.
- W2582168067 hasConceptScore W2582168067C2777180221 @default.
- W2582168067 hasConceptScore W2582168067C2777538456 @default.
- W2582168067 hasConceptScore W2582168067C2778199505 @default.
- W2582168067 hasConceptScore W2582168067C2779306644 @default.
- W2582168067 hasConceptScore W2582168067C2780473172 @default.
- W2582168067 hasConceptScore W2582168067C2780668416 @default.
- W2582168067 hasConceptScore W2582168067C555293320 @default.
- W2582168067 hasConceptScore W2582168067C61511704 @default.
- W2582168067 hasConceptScore W2582168067C71924100 @default.
- W2582168067 hasIssue "1" @default.
- W2582168067 hasLocation W25821680671 @default.
- W2582168067 hasLocation W25821680672 @default.
- W2582168067 hasOpenAccess W2582168067 @default.
- W2582168067 hasPrimaryLocation W25821680671 @default.
- W2582168067 hasRelatedWork W1868211825 @default.
- W2582168067 hasRelatedWork W1999742865 @default.
- W2582168067 hasRelatedWork W2017030704 @default.
- W2582168067 hasRelatedWork W2041584807 @default.
- W2582168067 hasRelatedWork W2117308800 @default.
- W2582168067 hasRelatedWork W2411649122 @default.
- W2582168067 hasRelatedWork W2971713860 @default.
- W2582168067 hasRelatedWork W3126557659 @default.
- W2582168067 hasRelatedWork W4205642424 @default.
- W2582168067 hasRelatedWork W4232297569 @default.
- W2582168067 hasVolume "19" @default.
- W2582168067 isParatext "false" @default.
- W2582168067 isRetracted "false" @default.
- W2582168067 magId "2582168067" @default.
- W2582168067 workType "article" @default.